GENB Generate Biomedicines, Inc.

NASDAQ
$16.39

Generate Biomedicines, Inc. (GENB) SEC Filings

Everything GENB has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

19 filings
Date Form Filing
144
144
8-K Other Reg Fd · Reg Fd
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.